BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 1337403)

  • 21. [Epidemiology of FeLV and FIV infection in the Federal Republic of Germany].
    Fuchs A; Binzel L; Lonsdorfer M
    Tierarztl Prax; 1994 Jun; 22(3):273-7. PubMed ID: 8048038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins.
    Avrameas A; Strosberg AD; Moraillon A; Sonigo P; Pancino G
    Res Virol; 1993; 144(3):209-18. PubMed ID: 7689247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
    Grosenbaugh DA; Leard T; Pardo MC
    J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of antibody response following vaccination against feline immunodeficiency virus.
    Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
    J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feline immunodeficiency virus (FIV) infection in cats at necropsy: a serological study.
    Holznagel E; Lutz H; Steinhauer D; Reinacher M
    J Comp Pathol; 1997 May; 116(4):339-52. PubMed ID: 9179747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination against feline retrovirus infections].
    Horzinek MC
    Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of 4 Point-of-Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus.
    Levy JK; Crawford PC; Tucker SJ
    J Vet Intern Med; 2017 Mar; 31(2):521-526. PubMed ID: 28158913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988).
    Shelton GH; Grant CK; Cotter SM; Gardner MB; Hardy WD; DiGiacomo RF
    J Acquir Immune Defic Syndr (1988); 1990; 3(6):623-30. PubMed ID: 2159993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement after feline immunodeficiency virus vaccination.
    Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of FIV antibodies and FeLV antigens in free-roaming cats in the capital area of Finland.
    Sukura A; Salminen T; Lindberg LA
    Acta Vet Scand; 1992; 33(1):9-14. PubMed ID: 1317991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
    Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
    Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of feline immunodeficiency virus infection in bone marrow of cats.
    Beebe AM; Gluckstern TG; George J; Pedersen NC; Dandekar S
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):37-49. PubMed ID: 1337401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-infection with feline retrovirus is related to changes in immunological parameters of cats with sporotrichosis.
    de Miranda LHM; Meli M; Conceição-Silva F; Novacco M; Menezes RC; Pereira SA; Sugiarto S; Dos Reis ÉG; Gremião IDF; Hofmann-Lehmann R
    PLoS One; 2018; 13(11):e0207644. PubMed ID: 30500849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxoplasma gondii, Dirofilaria immitis, feline immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infections in stray and pet cats (Felis catus) in northwest China: co-infections and risk factors.
    Cong W; Meng QF; Blaga R; Villena I; Zhu XQ; Qian AD
    Parasitol Res; 2016 Jan; 115(1):217-23. PubMed ID: 26362646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy.
    Bandecchi P; Matteucci D; Baldinotti F; Guidi G; Abramo F; Tozzini F; Bendinelli M
    Vet Immunol Immunopathol; 1992 Mar; 31(3-4):337-45. PubMed ID: 1317073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of feline leukemia virus and antibodies to feline immunodeficiency virus in cats in Norway.
    Ueland K; Lutz H
    Zentralbl Veterinarmed B; 1992 Feb; 39(1):53-8. PubMed ID: 1316024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
    Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
    Siebelink CH; Windrich RW; Chu I; Groen J; Weijer K; UytdeHaag FG; Osterhaus AD
    Dev Biol Stand; 1990; 72():189-96. PubMed ID: 2178115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.